Miriam Schlee
Robert Bosch Hospital(DE)Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)
Publications by Year
Research Areas
Antimicrobial Peptides and Activities, Probiotics and Fermented Foods, Pediatric health and respiratory diseases, Infant Nutrition and Health, Gut microbiota and health
Most-Cited Works
- → NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression(2004)795 cited
- → NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells byEscherichia coliNissle 1917: a Novel Effect of a Probiotic Bacterium(2004)467 cited
- → Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2(2008)351 cited
- → Induction of Human β-Defensin 2 by the ProbioticEscherichia coliNissle 1917 Is Mediated through Flagellin(2007)308 cited
- → Antimicrobial host defense in the upper gastrointestinal tract(2008)19 cited
- → Das Probiotikum E. coli Nissle 1917 induziert humanes beta Defensin-2 in Abhängigkeit von NFkB in intestinalen Epithelzellen(2015)1 cited
- → T1251 Antimicrobial Host Defense in the Upper Gastrointestinal Tract(2008)
- → O0033 THE PROBIOTIC STRAIN E. COLI NISSLE 1917 INDUCES HUMAN BETA DEFENSIN‐2 BY A NF‐k‐B DEPENDENT MECHANISM IN CACO‐2 CELLS(2004)
- → Pathomechanismus des Morbus Crohn mit NOD-2 (CARD 15) Mutation: defiziente mukosale Defensinexpression bei intakter Zytokinexpression(2015)
- Probiotic bacteria enhance the antibacterial barrier of enterocytes: insights into their mechanism of action(2007)